Compare Merck & Co., Inc. (MRK) vs Uranium Energy Corp (UEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Uranium Energy Corp — how do they compare? Merck & Co., Inc. trades at $145.6 (market cap $351.28B), while Uranium Energy Corp trades at $9.19 (market cap $4.53B). The key difference: Merck & Co., Inc. is far larger — about 77.5× Uranium Energy Corp's market cap, and Merck & Co., Inc. pays a 2.39% dividend while Uranium Energy Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Merck & Co., Inc. for 98 Days and Uranium Energy Corp for 37 Days on average.
| MRK | UEC | |
|---|---|---|
Market Cap | $351.28B | $4.53B |
Volume | 7,969,665 | 10,888,578 |
Sector | Health | Energy |
52-Week High | $156.43 | $20.14 |
52-Week Low | $82.49 | $9.04 |
Typical Hold Time | 98 Days | 37 Days |
Enterprise Value | $398.04B | $4.03B |
Dividend Yield | 2.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $142.40, down 0.28% on the day, with a bearish technical signal and key support at $140. The company reported strong earnings beats in recent quarters, with Q3 2026 EPS expected at $2.14. Revenue grew to $65.01B in 2025, and net income reached $18.25B, though the P/E ratio is elevated at 113.9. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline.
The outlook for MRK is mixed, with solid fundamentals and analyst optimism countered by high valuation and bearish technicals. The consensus price target of $158.78 suggests upside potential, but investors face risks from competitive pressures and integration challenges from recent M&A activity. Earnings growth and pipeline developments remain key catalysts.
Uranium Energy (UEC) trades at $9.14, down 3.48% in the last session, amid bearish technical signals despite strong analyst support. The company reported fiscal 2026 revenue of $37 million but posted a net loss of $137 million, reflecting ongoing operational challenges. Recent news highlights UEC's expansion to two operating mines and strong uranium pricing at $93.13 per pound, though production sustainability remains unproven. Technical indicators show bearish momentum with resistance at $10 and support at $9.
UEC presents a high-risk opportunity with significant analyst optimism (87.5% buy ratings) and a consensus price target of $16.06, offering 75% upside potential. However, persistent negative earnings, cash flow challenges, and dependence on uranium market dynamics pose substantial risks. Investors should weigh the company's strategic positioning in domestic uranium production against its current financial performance and execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Uranium Energy Corp
Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →
